InvestLog
MLEC Moolec Science S.A. logo

MLEC Moolec Science S.A.

Healthcare
$7.77+5.51%ClosedMarket Cap: $5.6M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-0.05

P/S

0.02

EV/EBITDA

-3.65

DCF Value

$3,175.65

FCF Yield

-533.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

34.2%

Operating Margin

-3.1%

Net Margin

-33.4%

ROE

376.8%

ROA

-54.4%

ROIC

-5.3%

Financials

View All
PeriodRevenueNet IncomeEPS
FY null$333.6M$-111.5M$—
Q2 null$2.6M$-2.4M$—
Q1 null$1.6M$-1.9M$—
Q4 null$1.5M$-2.5M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$45.00

Target (Median)

$45.00

Target Range

$45.00 - $45.00

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Core Daniel Joaquindirector
SellWed Apr 15
Falottico Valeria Inesofficer: Chief Financial Officer
SellThu Mar 19
Falottico Valeria Inesofficer: Chief Financial Officer
SellThu Mar 19
Falottico Valeria Inesofficer: Chief Financial Officer
SellThu Mar 19
Varela Lorenzo Romualdo Marianodirector
SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

LU

Exchange

—

Beta

0.37

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

Peers

DRMA logoDRMAELAB logoELABGLMD logoGLMDGTBP logoGTBPNCEL logoNCELNKGN logoNKGNTIVC logoTIVCVRAX logoVRAXWINT logoWINTXRTX logoXRTX